These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24899083)

  • 21. Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.
    Felix AS; McLaughlin EM; Caan BJ; Cohn DE; Anderson GL; Paskett ED
    Int J Cancer; 2020 Jul; 147(2):404-412. PubMed ID: 31618444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Patterns Among Women Diagnosed With Stage I-III Triple-negative Breast Cancer.
    Sineshaw HM; Freedman RA; DeSantis CE; Jemal A
    Am J Clin Oncol; 2018 Oct; 41(10):997-1007. PubMed ID: 29278527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.
    Yancik R; Wesley MN; Ries LA; Havlik RJ; Edwards BK; Yates JW
    JAMA; 2001 Feb; 285(7):885-92. PubMed ID: 11180731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
    Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
    JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer.
    Epstein AJ; Wong YN; Mitra N; Vachani A; Hin S; Yang L; Smith-McLallen A; Armstrong K; Groeneveld PW
    J Clin Oncol; 2015 Dec; 33(36):4259-67. PubMed ID: 26598749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of guideline-concordant initial systemic treatment with clinical and economic outcomes among older women with metastatic breast cancer in the United States.
    Vyas A; Mantaian T; Kamat S; Kurian S; Kogut S
    J Geriatr Oncol; 2021 Sep; 12(7):1092-1099. PubMed ID: 34099411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer.
    Field TS; Bosco JL; Prout MN; Gold HT; Cutrona S; Pawloski PA; Ulcickas Yood M; Quinn VP; Thwin SS; Silliman RA
    J Am Coll Surg; 2011 Dec; 213(6):757-65. PubMed ID: 22014658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
    Schonberg MA; Marcantonio ER; Li D; Silliman RA; Ngo L; McCarthy EP
    J Clin Oncol; 2010 Apr; 28(12):2038-45. PubMed ID: 20308658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer.
    Denu RA; Hampton JM; Currey A; Anderson RT; Cress RD; Fleming ST; Lipscomb J; Sabatino SA; Wu XC; Wilson JF; Trentham-Dietz A
    Cancer Epidemiol; 2016 Feb; 40():7-14. PubMed ID: 26605428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level.
    Verschoor AM; Kuijer A; Verloop J; Van Gils CH; Sonke GS; Jager A; van Dalen T; Elias SG
    Breast Cancer Res Treat; 2016 Sep; 159(2):357-65. PubMed ID: 27514397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer.
    Kong AL; Nattinger AB; McGinley E; Pezzin LE
    Breast Cancer Res Treat; 2018 Sep; 171(2):477-488. PubMed ID: 29869776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women.
    Owusu C; Lash TL; Silliman RA
    Breast Cancer Res Treat; 2007 Apr; 102(2):227-36. PubMed ID: 17004115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers.
    Brewster AM; Etzel C; Zhou R; Wong Y; Edge S; Blayney DW; Wilson J; Hudis C; Ottesen R; Hughes ME; Weeks JC; Theriault RL
    Breast Cancer Res Treat; 2011 Dec; 130(3):897-904. PubMed ID: 21809116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hospital volume on processes of breast cancer care: A National Cancer Data Base study.
    Yen TW; Pezzin LE; Li J; Sparapani R; Laud PW; Nattinger AB
    Cancer; 2017 May; 123(6):957-966. PubMed ID: 27861746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes over time in the impact of gene-expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study.
    Kuijer A; Drukker CA; Elias SG; Smorenburg CH; Th Rutgers EJ; Siesling S; van Dalen T
    Int J Cancer; 2016 Aug; 139(4):769-75. PubMed ID: 27062369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.
    Griggs JJ; Culakova E; Sorbero ME; Poniewierski MS; Wolff DA; Crawford J; Dale DC; Lyman GH
    J Clin Oncol; 2007 Jun; 25(18):2522-7. PubMed ID: 17577029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
    Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
    [No Abstract]   [Full Text] [Related]  

  • 38. Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing.
    Roberts MC; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes KE; Troester MA; Carey LA; Wheeler SB
    Breast Cancer Res Treat; 2015 Aug; 153(1):191-200. PubMed ID: 26216535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or].
    Coudert B; Chaplain G; Milan C; Janoray P
    Bull Cancer; 1996 Jan; 83(1):54-62. PubMed ID: 8672857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women.
    Keegan TH; Press DJ; Tao L; DeRouen MC; Kurian AW; Clarke CA; Gomez SL
    Breast Cancer Res; 2013; 15(5):R95. PubMed ID: 24131591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.